GH Research (STU:1KA) ROE % Adjusted to Book Value : -10.10% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is GH Research ROE % Adjusted to Book Value?

GH Research's ROE % for the quarter that ended in Dec. 2024 was -19.69%. GH Research's PB Ratio for the quarter that ended in Dec. 2024 was 1.95. GH Research's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -10.10%.

GH Research ROE % Adjusted to Book Value Historical Data

The historical data trend for GH Research's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research ROE % Adjusted to Book Value Chart

GH Research Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-10.27

GH Research Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-6.83	-14.81	-10.10

Competitive Comparison of GH Research's ROE % Adjusted to Book Value

For the Biotechnology subindustry, GH Research's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GH Research's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GH Research's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GH Research's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

GH Research ROE % Adjusted to Book Value Calculation

GH Research's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-20.02%	/	1.95
	=	-10.27%

GH Research's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-19.69%	/	1.95
	=	-10.10%

GH Research ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GH Research's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

GHRS:USA

Address

Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95

Website

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

GH Research Headlines

No Headlines